Analysis of nucleotide diversity of NAT2 coding region reveals homogeneity across Native American populations and high intra-population diversity

Pharmacogenomics Journal

Volumn 7, Issue 2, 2007, Pages 144-152

  Fuselli, S ^a,b   Gilman, R H ^c   Chanock, S J ^d   Bonatto, S L ^e   De Stefano, G ^f   Evans, C A ^c,g,h   Labuda, D ⁱ   Luiselli, D ^j   Salzano, F M ^k   Soto, G ^g   Vallejo, G ^l   Sajantila, A ^a   Pettener, D ^j   Tarazona Santos, E ^d,m  

^a UNIVERSITY OF HELSINKI   (Finland)

^b UNIVERSITY OF FERRARA   (Italy)

^c JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^d NATIONAL CANCER INSTITUTE   (United States)

^e PONTIFICAL CATHOLIC UNIVERSITY OF RIO GRANDE DO SUL   (Brazil)

^f UNIVERSITY OF ROME TOR VERGATA   (Italy)

^g ASOCIACIÓN BENÉFICA PRISMA   (Peru)

^h IMPERIAL COLLEGE LONDON   (United Kingdom)

ⁱ UNIVERSITY OF MONTREAL   (Canada)

^j UNIVERSITY OF BOLOGNA   (Italy)

^k FEDERAL UNIVERSITY OF RIO GRANDE DO SUL   (Brazil)

^l UNIVERSIDAD DEL TOLIMA   (Colombia)

^m FEDERAL UNIVERSITY OF MINAS GERAIS   (Brazil)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ARYLAMINE ACETYLTRANSFERASE;

AMERICAN INDIAN; ARTICLE; GENE LOCUS; GENE SEQUENCE; GENETIC ISOLATION BY DISTANCE; GENETIC VARIABILITY; GEOGRAPHICAL VARIATION (SPECIES); HAPLOTYPE; HUMAN; NUCLEOTIDE SEQUENCE; PHARMACOGENETICS; PHENOTYPE; POPULATION GENETICS; PRIORITY JOURNAL; PROMOTER REGION; RUSSIAN FEDERATION; SEQUENCE ANALYSIS; WESTERN HEMISPHERE;

ACETYLATION; AMERICAS; ARYLAMINE N-ACETYLTRANSFERASE; DNA MUTATIONAL ANALYSIS; EVOLUTION, MOLECULAR; GENE FREQUENCY; GENETICS, POPULATION; GENOTYPE; HAPLOTYPES; HUMANS; INDIANS, NORTH AMERICAN; MUTATION; OPEN READING FRAMES; PHENOTYPE; POLYMORPHISM, SINGLE NUCLEOTIDE; SIBERIA; VARIATION (GENETICS);

EID: 34147210676     PISSN: 1470269X     EISSN: 14731150     Source Type: Journal    
DOI: 10.1038/sj.tpj.6500407     Document Type: Article

References (64)

1. American Thoracic Society/Centers for Disease Control and Prevention/ Infectious Diseases Society of America. Treatment of tuberculosis. Am J Respir Crit Care Med 2003; 167: 603-662.
2. Grimwade K, Gilks C. Cotrimoxazole prophylaxis in adults infected with HIV in low-income countries. Curr Opin Infect Dis 2001; 14: 507-512.
3. Hein DW. Molecular genetics and function of NAT1 and NAT2: Role in aromatic amine metabolism and carcinogenesis. Mutat Res 2002; 506-507: 65-77.
4. Grantham R. Amino acid difference formula to help explain protein evolution. Science 1974; 185: 862-864.
5. Blum M, Grant DM, McBride W, Heim M, Meyer UA. Human arylamine N acetyltransferase genes: Isolation, chromosomal localization, and functional expression. DNA Cell Biol 1990; 9: 193-203.
6. Cascorbi I, Drakoulis N, Brockmoller J, Maurer A, Sperling K, Roots I. Arylamine N-acetyltransferase (NAT2) mutations and their allelic linkage in unrelated Caucasian individuals: Correlation with phenotypic activity. Am J Hum Genet 1995; 57: 581-592.
7. Hein DW, Doll MA, Fretland AJ, Leff MA, Webb SJ, Xiao GH et al. Molecular genetics and epidemiology of the NAT1 and NAT2 acetylation polymorphisms. Cancer Epidemiol Biomarkers Prev 2000; 9: 29-42.
8. Shishikura K, Hohjoh H, Tokunaga K. Novel allele containing 190C>T nonsynonymous substitution in the N-acetyltransferase (NAT2) gene. Hum Mut 2000; 15: 581.
9. Zang Y, Zhao S, Doll MA, States JC, Hein DW. The T341C (Ile114Thr) polymorphism of N-acetyltransferase 2 yields slow acetylator phenotype by enhanced protein degradation. Pharmacogenetics 2004; 14: 717-723.
10. Lin HJ, Han CY, Lin BK, Hardy S. Ethnic distribution of slow acetylator mutations in the polymorphic N-acetyltransferase (NAT2) gene. Pharmacogenetics 1994; 4: 125-134.
11. Cascorbi I, Roots I. Pitfalls in N-acetyltransferase 2 genotyping. Pharmacogenetics 1999; 9: 123-127.
12. Donald PR, Sirgel FA, Venter A, Parkin DP, Seifart HI, van de Wal BW et al. The influence of human N-acetyltransferase genotype on the early bactericidal activity of isoniazid. Clin Infect Dis 2004; 39: 1425-1430.
13. Parkin DP, Vandenplas S, Botha FJ, Vandenplas ML, Seifart HI, van Helden PD et al. Trimodality of isoniazid elimination: Phenotype and genotype in patients with tuberculosis. Am J Respir Crit Care Med 1997; 155: 1717-1722.
14. Kaufmann GR, Wenk M, Taeschner W, Peterli B, Gyr K, Meyer UA et al. N-acetyltransferase 2 polymorphism in patients infected with human immunodeficiency virus. Clin Pharmacol Ther 1996; 60 62-67.
15. O'Neil WM, Drobitch RK, MacArthur RD, Farrough MJ, Doll MA, Fretland AJ et al. Acetylator phenotype and genotype in patients infected with HIV: Discordance between methods for phenotype determination and genotype. Pharmacogenetics 2000; 10: 171-182.
16. Evans DAP, Manley KA, McKusick VA. Genetic control of isoniazid metabolism in man. BMJ 1960; 2: 485-491.
17. Siddiqui MA, Khan IA. Isoniazid-induced lupus erythematosus presenting with cardiac tamponade. Am J Ther 2002; 9: 163-165.
18. Maddrey WC. Drug-induced hepatotoxicity: 2005. J Clin Gastroenterol 2005; 39(Suppl 2): S83-S89.
19. Mitchison DA. How drug resistance emerges as a result of poor compliance during short course chemotherapy for tuberculosis. Int J Tuberc Lung Dis 1998; 2: 10-15.
20. Pande JN, Singh SP, Khilnani GC, Khilnani S, Tandon RK. Risk factors for hepatotoxicity from antituberculosis drugs: A case-control study. Thorax 1996; 51: 132-136.
21. Ohno M, Yamaguchi I, Yamamoto I, Fukuda T, Yokota S, Maekura R et al. Slow N-acetyltransferase 2 genotype affects the incidence of isoniazid and rifampicin-induced hepatotoxicity. Int J Tuberc Lung Dis 2000; 4: 256-261.
22. Yew WW. Risk factors for hepatotoxicity during anti-tuberculosis chemotherapy in Asian populations. Int J Tuberc Lung Dis 2001; 5: 99-100.
23. Huang YS, Chem HD, Su WJ, Wu JC, Lai SL, Yang SY et al. Polymorphism of the N-acetyltransferase 2 gene as a susceptibility risk factor for antituberculosis drug-induced hepatitis. Hepatology 2002; 35: 883-889.
24. Mitchell JR, Long MW, Thorgeirsson UP, Jollow DJ. Acetylation rates and monthly liver function tests during one year of isoniazid preventive therapy. Chest 1975; 68: 181-190.
25. Yamamoto T, Suou T, Hirayama C. Elevated serum aminotransferase induced by isoniazid in relation to isoniazid acetylator phenotype. Hepatology 1986; 6: 295-298.
26. Santos FR, Pandya A, Tyler-Smith C, Pena SD, Schanfield M, Leonard WR et al. The central Siberian origin for native American Y chromosomes. Am J Hum Genet 1999; 64: 619-628.
27. Zegura SL, Karafet TM, Zhivotovsky LA, Hammer MF. High-resolution SNPs and microsatellite haplotypes point to a single, recent entry of Native American Y chromosomes into the Americas. Mol Biol Evol 2004; 21: 164-175.
28. Arias TD, Jorge LF, Griese EU, Inaba T, Eichelbaum M. Polymorphic N-acetyltransferase (NAT2) in Amerindian populations of Panama and Colombia: High frequencies of point mutation 857A, as found in allele S3/ M3. Pharmacogenetics 1993; 3: 328-331.
29. Jorge-Nebert LF, Eichelbaum M, Griese EU, Inaba T, Arias TD. Analysis of six SNPs of NAT2 in Ngawbe and Embera Amerindians of Panama and determination of the Embera acetylation phenotype using caffeine. Pharmacogenetics 2002; 12: 39-48.
30. Wright S. Isolation by distance. Genetics 1943; 28: 114-138.
31. Fuselli S, Tarazona-Santos E, Dupanloup I, Soto A, Luiselli D, Pettener D. Mitochondrial DNA diversity in South America and the genetic history of Andean highlanders. Mol Biol Evol 2003; 20: 1682-1691.
32. Fretland AJ, Leff MA, Doll MA, Hein DW. Functional characterization of human N-acetyltransferase 2 (NAT2) single nucleotide polymorphisms. Pharmacogenetics 2001; 11: 207-215.
33. Patin E, Barreiro LB, Sabeti PC, Austerlitz F, Luca F, Sajantila A et al. Deciphering the ancient and complex evolutionary history of human arylamine N-acetyltransferase genes. Am J Hum Genet 2006; 78: 423-436.
34. Sekine A, Saito S, Iida A, Mitsunobu Y, Higuchi S, Harigae S et al. Identification of single-nucleotide polymorphisms (SNPs) of human N-acetyltransferase genes NAT1, NAT2, AANAT, ARD1 and L1CAM in the Japanese population. J Hum Genet 2001; 46: 314-319.
35. Lee SY, Lee KA, Ki CS, Kwon OJ, Kim HJ, Chung MP et al. Complete sequencing of a genetic polymorphism in NAT2 in the Korean population. Clin Chem 2002; 48: 775-777.
36. Grant DM, Hughes NC, Janezic SA, Goodfellow GH, Chen HJ, Gaedigk A et al. Human acetyltransferase polymorphisms. Mutat Res 1997; 376: 61-70.
37. Meyer UA, Zanger UM. Molecular mechanisms of genetic polymorphisms of drug metabolism. Annu Rev Pharmacol Toxicol 1997; 37: 269-296.
38. Delomenie C, Sica L, Grant DM, Krishnamoorthy R, Dupret J-M. Genotyping of the polymorphic N-acetyltransferase (NAT2*) gene locus in two native African populations. Pharmacogenetics 1996; 6: 177-185.
39. Rosenberg NA, Pritchard JK, Weber JL, Cann HM, Kidd KK, Zhivotovsky LA et al. Genetic structure of human populations. Science 2002; 298: 2381-2385.
40. Tarazona-Santos E, Carvalho-Silva DR, Pettener D, Luiselli D, De Stefano GF, Labarga CM et al. Genetic differentiation in South Amerindians is related to environmental and cultural diversity: Evidence from the Y chromosome. Am J Hum Genet 2001; 68: 1485-1496.
41. Nei M. Molecular Evolutionary Genetics. Columbia University Press: New York, 1987.
42. Tajima F. Evolutionary relationship of DNA sequences in finite populations. Genetics 1983; 105: 437-460.
43. Watterson GA. On the number of segregating sites in genetical models without recombination. Theor Popul Biol 1975; 7: 256-276.
44. Jorde LB, Watkins WS, Bamshad MJ, Dixon ME, Ricker CE, Seielstad MT et al. The distribution of human genetic diversity: A comparison of mitochondrial, autosomal, and Y-chromosome data. Am J Hum Genet 2000; 66: 979-988.
45. Altshuler D, Brooks LD, Chakravarti A, Collins FS, Daly MJ, Donnelly P, International HapMap Consortium. A haplotype map of the human genome. Nature 2005; 437: 1299-1320.
46. Sokal R. Ecological parameters inferred from spatial correlograms. In G Patil, M Rozenzweig (eds). Contemporary Quantitative Ecology and Related Econometrics. International Co-operative Publishing House: Fairland, MD, 1979, pp 167-196.
47. Bertorelle G, Barbujani G. Analysis of DNA diversity by spatial autocorrelation. Genetics 1995; 140: 811-819.
48. Sokal RR, Oden NL. Spatial autocorrelation in biology. 1. Methodology. Biol J Linn Soc 1978; 10: 199-228.
49. Parra FC, Amado RC, Lambertucci JR, Rocha J, Antunes CM, Pena SD. Color and genomic ancestry in Brazilians. Proc Natl Acad Sci USA 2003; 100: 177-182.
50. Suarez-Kurtz G. Pharmacogenomics in admixed populations. Trends Pharmacol Sci 2005; 26: 196-201.
51. Mulligan CJ, Hunley K, Cole S, Long JC. Population genetics, history, and health patterns in native Americans. Annu Rev Genomics Hum Genet 2004; 5: 295-315.
52. Serre D, Paabo S. Evidence for gradients of human genetic diversity within and among continents. Genome Res 2004; 14: 1679-1685.
53. Ramachandran S, Deshpande O, Roseman CC, Rosenberg NA, Feldman MW, Cavalli-Sforza LL. Support from the relationship of genetic and geographic distance in human populations for a serial founder effect originating in Africa. Proc Natl Acad Sci USA 2005; 102: 15942-15947.
54. Cavalli-Sforza LL, Menozzi P, Piazza A. The History and Geography of Human Genes. Princeton University Press: Princeton, NJ, 1994.
55. Barbujani G, Belle EM. Genomic boundaries between human populations. Hum Hered 2006; 61: 15-21.
56. Tajima F. Statistical method for testing the neutral mutation hypothesis by DNA polymorphism. Genetics 1989; 123: 585-595.
57. Rickards O, Martinez-Labarga C, Lum JK, De Stefano GF, Cann RL. mtDNA history of the Cayapa Amerinds of Ecuador: Detection of additional founding lineages for the Native American populations. Am J Hum Genet 1999; 65: 519-530.
58. Luiselli D, Simoni L, Tarazona-Santos E, Pastor S, Pettener D. Genetic structure of Quechua-speakers of the Central Andes and geographic patterns of gene frequencies in South Amerindian populations. Am J Phys Anthropol 2000; 113: 5-17.
59. Cann HM, de Toma C, Cazes L, Legrand MF, Morel V, Piouffre L et al. A human genome diversity cell line panel. Science 2002; 296: 261-262.
60. Stephens M, Donnelly P. A comparison of Bayesian methods for haplotype reconstruction from population genotype data. Am J Hum Genet 2003; 73: 1162-1169.
61. Clement M, Posada D, Crandall KA. TCS: A computer program to estimate gene genealogies. Mol Ecol 2000; 9: 1657-1659.
62. Schneider S, Roessli D, Excoffier L. Arlequin Ver. 2.0: A Software for Population Genetics Data Analysis. Genetics and Biometry Laboratory, University of Geneva: Switzerland, 2000.
63. Rosenberg M. Pattern Analysis, Spatial Statistics, and Geographic Exegesis, version 1.1, 1.1 edn. Department of Biology, Arizona State University: Tempe, 2001.
64. Pritchard JK, Stephens M, Donnelly P. Inference of population structure using multilocus genotype data. Genetics 2000; 155 945-959.